| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 17 | 2019 | 1891 | 1.650 |
Why?
|
| Ischemia | 12 | 2024 | 370 | 1.610 |
Why?
|
| Myocytes, Cardiac | 10 | 2017 | 657 | 1.520 |
Why?
|
| Membrane Proteins | 8 | 2015 | 1610 | 1.150 |
Why?
|
| Cell Hypoxia | 10 | 2017 | 100 | 1.130 |
Why?
|
| Neovascularization, Physiologic | 14 | 2021 | 210 | 1.110 |
Why?
|
| Hindlimb | 6 | 2017 | 76 | 1.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 13 | 2024 | 443 | 1.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2012 | 87 | 1.010 |
Why?
|
| Chromogranins | 6 | 2022 | 28 | 0.900 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 260 | 0.890 |
Why?
|
| Genetic Therapy | 6 | 2024 | 719 | 0.870 |
Why?
|
| Animals | 72 | 2024 | 34781 | 0.840 |
Why?
|
| Neovascularization, Pathologic | 7 | 2022 | 257 | 0.840 |
Why?
|
| Acidosis | 4 | 2012 | 101 | 0.840 |
Why?
|
| Biological Therapy | 1 | 2024 | 25 | 0.840 |
Why?
|
| Peripheral Arterial Disease | 3 | 2024 | 320 | 0.820 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 1046 | 0.790 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2007 | 613 | 0.760 |
Why?
|
| Signal Transduction | 15 | 2022 | 4703 | 0.740 |
Why?
|
| Myocardium | 8 | 2019 | 906 | 0.710 |
Why?
|
| Hypoxia | 5 | 2014 | 258 | 0.690 |
Why?
|
| Choroidal Neovascularization | 4 | 2024 | 34 | 0.630 |
Why?
|
| Myocardial Ischemia | 4 | 2015 | 342 | 0.620 |
Why?
|
| Nephritis, Hereditary | 4 | 2023 | 20 | 0.610 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 168 | 0.600 |
Why?
|
| Femoral Artery | 2 | 2017 | 166 | 0.590 |
Why?
|
| Calcium | 4 | 2015 | 1078 | 0.590 |
Why?
|
| Mice | 38 | 2024 | 18460 | 0.580 |
Why?
|
| Regeneration | 3 | 2016 | 226 | 0.580 |
Why?
|
| Muscle, Skeletal | 5 | 2017 | 1034 | 0.570 |
Why?
|
| Cells, Cultured | 14 | 2019 | 3037 | 0.550 |
Why?
|
| MicroRNAs | 5 | 2019 | 916 | 0.530 |
Why?
|
| Oxygen | 6 | 2022 | 569 | 0.530 |
Why?
|
| Retinopathy of Prematurity | 3 | 2022 | 64 | 0.520 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2007 | 129 | 0.500 |
Why?
|
| Rats | 13 | 2016 | 3608 | 0.500 |
Why?
|
| Oxidative Stress | 8 | 2019 | 803 | 0.480 |
Why?
|
| Calpain | 1 | 2015 | 43 | 0.470 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 46 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2011 | 21 | 0.460 |
Why?
|
| Collagen Type IV | 4 | 2023 | 20 | 0.460 |
Why?
|
| Heart Diseases | 3 | 2004 | 511 | 0.440 |
Why?
|
| Atherosclerosis | 5 | 2019 | 1007 | 0.440 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 363 | 0.440 |
Why?
|
| Enzyme Activation | 9 | 2015 | 615 | 0.440 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 258 | 0.430 |
Why?
|
| Cardiomegaly | 2 | 2012 | 125 | 0.420 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2024 | 226 | 0.400 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 33 | 0.390 |
Why?
|
| Sirtuins | 1 | 2012 | 20 | 0.390 |
Why?
|
| Apolipoproteins E | 4 | 2013 | 200 | 0.390 |
Why?
|
| Carbocyanines | 1 | 2012 | 10 | 0.390 |
Why?
|
| Mitochondria | 8 | 2019 | 747 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 4751 | 0.370 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 61 | 0.370 |
Why?
|
| Heart Failure | 4 | 2022 | 2383 | 0.370 |
Why?
|
| Endodeoxyribonucleases | 1 | 2012 | 46 | 0.370 |
Why?
|
| Receptor, Insulin | 1 | 2011 | 68 | 0.360 |
Why?
|
| Retinal Neovascularization | 3 | 2022 | 18 | 0.360 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 4680 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 189 | 0.350 |
Why?
|
| Cell Cycle | 2 | 2010 | 611 | 0.340 |
Why?
|
| Dietary Fats | 1 | 2012 | 279 | 0.340 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2016 | 87 | 0.330 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2011 | 175 | 0.330 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 85 | 0.320 |
Why?
|
| Osteopontin | 2 | 2021 | 52 | 0.320 |
Why?
|
| Phosphorylation | 7 | 2016 | 1608 | 0.320 |
Why?
|
| Hyperlipidemias | 2 | 2022 | 188 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 177 | 0.310 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2024 | 98 | 0.300 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2017 | 43 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2019 | 64 | 0.290 |
Why?
|
| Dyslipidemias | 1 | 2011 | 241 | 0.280 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 606 | 0.280 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 169 | 0.270 |
Why?
|
| Cell Movement | 5 | 2024 | 888 | 0.270 |
Why?
|
| Inflammation | 3 | 2023 | 1519 | 0.270 |
Why?
|
| Dependovirus | 2 | 2024 | 153 | 0.260 |
Why?
|
| Animals, Newborn | 5 | 2021 | 1033 | 0.260 |
Why?
|
| Autoantigens | 3 | 2022 | 106 | 0.260 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 376 | 0.260 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 20 | 0.260 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 51 | 0.250 |
Why?
|
| Exosomes | 2 | 2017 | 57 | 0.250 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2017 | 20 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 4 | 2022 | 1045 | 0.250 |
Why?
|
| Retinal Vessels | 3 | 2023 | 78 | 0.250 |
Why?
|
| Transfection | 7 | 2013 | 996 | 0.250 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 271 | 0.250 |
Why?
|
| Hyperglycemia | 1 | 2008 | 235 | 0.240 |
Why?
|
| Cell Proliferation | 8 | 2024 | 2507 | 0.240 |
Why?
|
| Genetic Vectors | 4 | 2024 | 925 | 0.230 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 2437 | 0.230 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2011 | 448 | 0.230 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 223 | 0.230 |
Why?
|
| Exercise Therapy | 2 | 2021 | 182 | 0.230 |
Why?
|
| Glycolysis | 2 | 2016 | 166 | 0.220 |
Why?
|
| Humans | 41 | 2024 | 131924 | 0.220 |
Why?
|
| Aging | 2 | 2010 | 1248 | 0.220 |
Why?
|
| Proteins | 1 | 2010 | 1035 | 0.220 |
Why?
|
| Laminin | 1 | 2024 | 72 | 0.220 |
Why?
|
| Antibodies | 2 | 2021 | 365 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2012 | 1410 | 0.220 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 238 | 0.210 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 35 | 0.210 |
Why?
|
| Diet | 1 | 2011 | 1125 | 0.210 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 38 | 0.210 |
Why?
|
| Stem Cell Transplantation | 2 | 2003 | 249 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 2443 | 0.210 |
Why?
|
| Drug Combinations | 1 | 2024 | 280 | 0.210 |
Why?
|
| Collagen | 1 | 2024 | 303 | 0.200 |
Why?
|
| China | 1 | 2024 | 290 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2018 | 800 | 0.200 |
Why?
|
| Gene Expression | 4 | 2015 | 1558 | 0.190 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 18 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2002 | 15 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2003 | 243 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 145 | 0.190 |
Why?
|
| Endometrium | 2 | 2016 | 277 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 1221 | 0.190 |
Why?
|
| Receptors, CXCR4 | 3 | 2014 | 70 | 0.190 |
Why?
|
| Macular Degeneration | 1 | 2024 | 127 | 0.190 |
Why?
|
| Proteomics | 2 | 2022 | 596 | 0.190 |
Why?
|
| Lower Extremity | 1 | 2024 | 188 | 0.180 |
Why?
|
| Heart | 2 | 2007 | 689 | 0.180 |
Why?
|
| Ischemic Preconditioning, Myocardial | 2 | 2014 | 14 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 1161 | 0.180 |
Why?
|
| Methionine Sulfoxide Reductases | 2 | 2011 | 5 | 0.180 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 687 | 0.180 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 58 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2003 | 150 | 0.170 |
Why?
|
| Mice, Knockout | 7 | 2022 | 3860 | 0.170 |
Why?
|
| Nicotine | 2 | 2013 | 118 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 200 | 0.170 |
Why?
|
| Zinc Fingers | 1 | 2001 | 122 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 56 | 0.170 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 547 | 0.170 |
Why?
|
| Hydrogen Peroxide | 4 | 2007 | 124 | 0.170 |
Why?
|
| Aortic Aneurysm | 1 | 2023 | 237 | 0.170 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 82 | 0.170 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 51 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 501 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2012 | 1077 | 0.170 |
Why?
|
| Obesity | 1 | 2012 | 2394 | 0.170 |
Why?
|
| Oxidation-Reduction | 4 | 2011 | 436 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 167 | 0.160 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2018 | 12 | 0.160 |
Why?
|
| Coronary Disease | 2 | 2003 | 684 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 490 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 224 | 0.160 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2019 | 13 | 0.150 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 10 | 0.150 |
Why?
|
| Retina | 5 | 2023 | 490 | 0.150 |
Why?
|
| Isoenzymes | 1 | 2000 | 223 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2000 | 110 | 0.150 |
Why?
|
| Retinal Diseases | 1 | 2021 | 179 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 346 | 0.150 |
Why?
|
| Corticosterone | 1 | 2019 | 60 | 0.150 |
Why?
|
| Blood Vessels | 2 | 2014 | 103 | 0.150 |
Why?
|
| Adenoviridae | 2 | 2016 | 595 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 364 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2003 | 812 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1046 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2003 | 785 | 0.140 |
Why?
|
| Lipoproteins, LDL | 2 | 2022 | 133 | 0.140 |
Why?
|
| Cytokines | 2 | 2017 | 1359 | 0.140 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 59 | 0.140 |
Why?
|
| Kidney | 2 | 2023 | 1330 | 0.140 |
Why?
|
| Collateral Circulation | 1 | 2017 | 43 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 508 | 0.140 |
Why?
|
| Cell Line | 6 | 2015 | 2718 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2015 | 138 | 0.130 |
Why?
|
| Gene Silencing | 2 | 2016 | 237 | 0.130 |
Why?
|
| Vascular Calcification | 1 | 2018 | 71 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2019 | 196 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2024 | 760 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 1347 | 0.130 |
Why?
|
| Models, Biological | 4 | 2016 | 1443 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 500 | 0.130 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2010 | 38 | 0.130 |
Why?
|
| Reperfusion | 1 | 2016 | 26 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 361 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2021 | 489 | 0.120 |
Why?
|
| Genomics | 1 | 2004 | 1647 | 0.120 |
Why?
|
| Oxidants | 3 | 2007 | 25 | 0.120 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2007 | 7 | 0.120 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2016 | 77 | 0.120 |
Why?
|
| Stilbenes | 1 | 2016 | 38 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 89 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 54 | 0.120 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 38 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2013 | 88 | 0.120 |
Why?
|
| Glucuronidase | 1 | 2015 | 30 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2015 | 56 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 62 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 126 | 0.120 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 136 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2003 | 2493 | 0.110 |
Why?
|
| Acetylation | 1 | 2015 | 191 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 305 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2012 | 698 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 2 | 2012 | 63 | 0.110 |
Why?
|
| Cell Death | 2 | 2007 | 241 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 1044 | 0.110 |
Why?
|
| Alkaline Phosphatase | 2 | 2018 | 97 | 0.100 |
Why?
|
| Blotting, Northern | 2 | 2004 | 252 | 0.100 |
Why?
|
| Cell Survival | 4 | 2016 | 866 | 0.100 |
Why?
|
| Tunica Intima | 2 | 2010 | 55 | 0.100 |
Why?
|
| CD36 Antigens | 1 | 2013 | 41 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 2 | 2017 | 612 | 0.100 |
Why?
|
| Stem Cells | 3 | 2013 | 732 | 0.100 |
Why?
|
| Leptin | 1 | 2014 | 219 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 1293 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2013 | 605 | 0.100 |
Why?
|
| Male | 12 | 2023 | 64870 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 373 | 0.100 |
Why?
|
| Mice, Inbred CBA | 1 | 2012 | 29 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2021 | 677 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2012 | 587 | 0.100 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2012 | 3 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 2011 | 275 | 0.100 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 516 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2006 | 827 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2024 | 51 | 0.090 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2022 | 64 | 0.090 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 94 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 236 | 0.090 |
Why?
|
| Kinetics | 2 | 2006 | 1129 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 2 | 2004 | 309 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 116 | 0.090 |
Why?
|
| Intravitreal Injections | 2 | 2022 | 154 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2023 | 526 | 0.090 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 103 | 0.090 |
Why?
|
| Threonine | 1 | 2011 | 61 | 0.090 |
Why?
|
| Protein Transport | 1 | 2012 | 369 | 0.090 |
Why?
|
| Methionine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Catalysis | 1 | 2011 | 139 | 0.080 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 192 | 0.080 |
Why?
|
| Diet Therapy | 1 | 2011 | 41 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2016 | 550 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2010 | 13 | 0.080 |
Why?
|
| G2 Phase | 1 | 2010 | 42 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 38 | 0.080 |
Why?
|
| Ligands | 1 | 2011 | 494 | 0.080 |
Why?
|
| Argonaute Proteins | 1 | 2010 | 31 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2011 | 183 | 0.080 |
Why?
|
| S Phase | 1 | 2010 | 76 | 0.080 |
Why?
|
| Serine | 1 | 2011 | 166 | 0.080 |
Why?
|
| G1 Phase | 1 | 2010 | 66 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 113 | 0.080 |
Why?
|
| Cyclins | 1 | 2010 | 100 | 0.080 |
Why?
|
| Escherichia coli Proteins | 2 | 2003 | 316 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 246 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 376 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2009 | 25 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2022 | 538 | 0.080 |
Why?
|
| Weight Gain | 1 | 2012 | 381 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 333 | 0.080 |
Why?
|
| Mitosis | 1 | 2010 | 196 | 0.080 |
Why?
|
| Time Factors | 5 | 2017 | 6440 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2010 | 268 | 0.080 |
Why?
|
| Macrophages | 1 | 2013 | 688 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1280 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1672 | 0.070 |
Why?
|
| Eating | 1 | 2011 | 381 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 294 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1693 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 36 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 623 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2010 | 442 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 482 | 0.070 |
Why?
|
| Apoptosomes | 1 | 2007 | 6 | 0.070 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 2 | 2018 | 4 | 0.070 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2007 | 36 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 2 | 2018 | 10 | 0.070 |
Why?
|
| Lipids | 1 | 2011 | 561 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 293 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2010 | 255 | 0.070 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 53 | 0.070 |
Why?
|
| Caspase 9 | 1 | 2007 | 76 | 0.060 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 8 | 0.060 |
Why?
|
| Foam Cells | 2 | 2019 | 24 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2006 | 32 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 65 | 0.060 |
Why?
|
| Dimerization | 1 | 2006 | 149 | 0.060 |
Why?
|
| Glucose | 1 | 2011 | 870 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2007 | 206 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 285 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 142 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 8 | 0.060 |
Why?
|
| Paracrine Communication | 2 | 2016 | 70 | 0.060 |
Why?
|
| Antioxidants | 2 | 2013 | 333 | 0.060 |
Why?
|
| Female | 10 | 2023 | 70584 | 0.060 |
Why?
|
| Aorta | 2 | 2019 | 550 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2019 | 152 | 0.060 |
Why?
|
| Anisomycin | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 23 | 0.060 |
Why?
|
| Antimycin A | 1 | 2004 | 6 | 0.060 |
Why?
|
| Acute Disease | 1 | 2008 | 1160 | 0.060 |
Why?
|
| Angiography | 1 | 2005 | 208 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 33 | 0.050 |
Why?
|
| Electron Transport | 1 | 2004 | 57 | 0.050 |
Why?
|
| Protein Binding | 2 | 2015 | 1730 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2024 | 92 | 0.050 |
Why?
|
| Rabbits | 1 | 2005 | 673 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 68 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 21 | 0.050 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2003 | 8 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 588 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 454 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 62 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2003 | 213 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 116 | 0.050 |
Why?
|
| Stents | 1 | 2009 | 868 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2007 | 548 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 230 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 23 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2003 | 117 | 0.050 |
Why?
|
| Adult | 1 | 2024 | 31536 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 59 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2002 | 39 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 90 | 0.050 |
Why?
|
| Indoles | 1 | 2003 | 201 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2002 | 52 | 0.050 |
Why?
|
| Cellular Senescence | 2 | 2016 | 199 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 487 | 0.050 |
Why?
|
| Necrosis | 1 | 2002 | 209 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 79 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 217 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 309 | 0.050 |
Why?
|
| Sulfhydryl Reagents | 1 | 2001 | 7 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 331 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 1 | 2005 | 515 | 0.050 |
Why?
|
| Capillaries | 1 | 2022 | 71 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 126 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2001 | 42 | 0.040 |
Why?
|
| Plasmids | 1 | 2002 | 459 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 174 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3351 | 0.040 |
Why?
|
| COS Cells | 1 | 2001 | 268 | 0.040 |
Why?
|
| Superoxides | 1 | 2001 | 133 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2001 | 101 | 0.040 |
Why?
|
| Cholesterol | 1 | 2024 | 558 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 100 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 4526 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 105 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2021 | 131 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 2645 | 0.040 |
Why?
|
| Systole | 1 | 2021 | 206 | 0.040 |
Why?
|
| Cysteine | 1 | 2001 | 142 | 0.040 |
Why?
|
| Diastole | 1 | 2021 | 181 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 743 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 295 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2002 | 470 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 36 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 514 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 588 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 551 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 52 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 396 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 5 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 65 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 58 | 0.040 |
Why?
|
| Ceramides | 1 | 2000 | 46 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 3404 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 515 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 93 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2001 | 731 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 2899 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 861 | 0.040 |
Why?
|
| Extremities | 1 | 2000 | 82 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 6226 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2019 | 21 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2000 | 82 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2000 | 119 | 0.040 |
Why?
|
| Neoplasms | 1 | 2014 | 2955 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 461 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 3011 | 0.040 |
Why?
|
| Binding Sites | 1 | 2001 | 1256 | 0.040 |
Why?
|
| Osteoprotegerin | 1 | 2018 | 13 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2018 | 11 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1284 | 0.040 |
Why?
|
| Forecasting | 1 | 2000 | 371 | 0.040 |
Why?
|
| Isoquinolines | 1 | 2018 | 40 | 0.040 |
Why?
|
| Prognosis | 1 | 2008 | 5007 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 54 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 728 | 0.030 |
Why?
|
| Gangrene | 1 | 2017 | 27 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 83 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2017 | 21 | 0.030 |
Why?
|
| Ligation | 1 | 2017 | 139 | 0.030 |
Why?
|
| Genome, Human | 1 | 2004 | 1331 | 0.030 |
Why?
|
| Culture Media | 1 | 2018 | 183 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 282 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 421 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 159 | 0.030 |
Why?
|
| Disease Progression | 1 | 2003 | 2221 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 212 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 63 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 697 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2018 | 163 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 192 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 541 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 404 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2674 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 439 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 44 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 285 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 126 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 54 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 105 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1555 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 1472 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2000 | 861 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1280 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 162 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 119 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 38 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2014 | 55 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 471 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 341 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 232 | 0.030 |
Why?
|
| Hypertension | 1 | 2002 | 1396 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 16 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 54 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 504 | 0.030 |
Why?
|
| Risk Factors | 1 | 2008 | 10933 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1978 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 923 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 118 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 263 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 571 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 240 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12991 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 107 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 822 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 247 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 308 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 1998 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2018 | 877 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 433 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 791 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 144 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 684 | 0.020 |
Why?
|
| Pregnancy | 1 | 2003 | 7543 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2010 | 9 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 664 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 876 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2010 | 46 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 430 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 112 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 89 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2010 | 75 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 811 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 109 | 0.020 |
Why?
|
| Tomography, Optical | 1 | 2009 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 133 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2009 | 39 | 0.020 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 11 | 0.020 |
Why?
|
| Benzylamines | 1 | 2009 | 19 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 18 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 25 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8542 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 118 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 62 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 241 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3678 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 326 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 698 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 129 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 98 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1547 | 0.020 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2007 | 64 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 53 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 57 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 550 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 412 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2008 | 232 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3770 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1422 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 986 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1881 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 3175 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 990 | 0.010 |
Why?
|